In this article, we will discuss Palonosetron Clinical Trials Effect (Metabolic). So, let’s get started.
Metabolic: 1%: hyperkalemia, < 1%: electrolyte fluctuations, hyperglycemia, metabolic acidosis, glycosuria, appetite decrease, anorexia.
In this article we will discuss Palonosetron Clinical Trials Effect (Metabolic)
In this article, we will discuss Palonosetron Clinical Trials Effect (Metabolic). So, let’s get started.
Metabolic: 1%: hyperkalemia, < 1%: electrolyte fluctuations, hyperglycemia, metabolic acidosis, glycosuria, appetite decrease, anorexia.
Subscribe now to keep reading and get access to the full archive.